Rhamnetin improves antioxidant status in the liver of Ehrlich solid tumor bearing mice

Main Article Content

Mustafa Nisari
Özlem Bozkurt
Tolga Ertekin
Dilek Ceylan
Neriman İnanç
Özge Al
Hatice Güler
Erdoğan Unur

Abstract

Objective: Rhamnetin, a flavanol, is in the subclasses of the flavonoids existing in plants. The antioxidant properties of several plants containing flavonoids have been extensively studied in several diseases including cancer. This study investigated the effects of rhamnetin on tumor masses, oxidant and antioxidant status in the livers of mice bearing Ehrlich solid tumor.


Material and Methods: Fifty male Balb/C mice weighing 25-30 g were used in the study. Ten mice were kept for Ehrlich ascites tumor (EAT) cells production and the remaining mice were randomly assigned to four groups containing 10 mice in each as healthy control and treatments receiving 1x106 EAT cells and EAT cells plus 100 µg/kg/day or 200 µg/kg/day rhamnetin via subcutaneous route. The tumor inhibition rates of rhamnetin treatments were calculated. The livers were analyzed for malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) levels.


Results: Compare to tumor control, both levels of rhamnetin suppressed tumor masses throughout the experiment. The MDA levels were increased whereas SOD and CAT activities were reduced by EAT cells injection in the liver of mice. The 100 µg/kg/day rhamnetin treatment decreased MDA level but 200 µg/kg/day rhamnetin had no significant effect on increased MDA level. The reduced liver SOD (p<0.001) and CAT (p<0.01) activities were elevated by both levels of rhamnetin injection.


Conclusions: The results of this study have revealed that rhamnetin suppresses tumor progression and improves antioxidant status in the livers of solid tumor-bearing mice.

Downloads

Download data is not yet available.

Article Details

How to Cite
NisariM., Bozkurt, Özlem, ErtekinT., CeylanD., İnançN., Al, Özge, GülerH., & UnurE. (2020). Rhamnetin improves antioxidant status in the liver of Ehrlich solid tumor bearing mice. Medical Science and Discovery, 7(5), 494-500. https://doi.org/10.36472/msd.v7i5.380
Section
Research Article

References

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017; 67: 7-30.

2. Kang JH, Kim EG, Seong KM, Youn HS, Kim JW, Kim J.Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines. J Biol Chem. 2013; (38): 27343-57.

3. Bebiş H, Akpunar D, Coşkun S, Özdemir S. Complementary and alternative treatments in patients with breast cancer: a literature review. Journal of Education and Research in Nursing 2014; 11(2): 6-14.

4. Özçelik G, Toprak D.Why is phytotherapy preferred? Ankara Med J. 2015; 15(2): 48-58.

5. Ferreira JFS, Luthria DL, Sasaki T, Heyerick A. Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisin against malaria and cancer. Molecules. 2010; 15: 3135-3170.

6. Park ES, Kang JC, Jang YC, Park JS, Jang SY, Kim DE, Kim B, Shin HS Cardioprotective effects of rhamnetin in H9c2 cardiomyoblast cells under H2O2-induced apoptosis. J Ethnopharmacol. 2014; 153(3): 552-560.

7. Kelly, GS. Quercetin. Alternative Med Rev. 2011; 16 (2): 172-194.

8. Ozipek M, Caliş I, Ertan M, Rüedi P. Rhamnetin 3-p-coumaroylrhamninoside from Rhamnus petiolaris. Phytochemistry. 1994; 37(1): 249-53.

9. de Brito ES, de Araujo PMC, Lin LZ, Harnly J. Determination of flavonoid components of cashew apple (Anacardium occidentale) by LC-DAD-ESI/MS. Food Chem. 2007; 105: 1112-1118.

10. Kim YJ. Rhamnetin attenuates melanogenesis by suppressing oxidative stress and pro-inflammatory mediators. Biol Pharm Bull. 2013; 36(8): 1341-1347.

11. Oak C, Bhaskaran N, Gupta S, Shukla S. Antiproliferative, antioxidant and antiapoptic effects of rhamnetin in human prostate cancer. Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.

12. Majewska M, Skrzycki M, Podsiad M, Czeczot H.Evaluation of antioxidant potential of flavonoids: An in vitro study. Acta Poleniae Pharmaceutica. 2011; 68(4): 611-615.

13. Sawa T, Nakao M, Akaike T, Ono K, Maeda H. Alkylperoxyl radical scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. J Agric Food Chem. 1999; 47: 397–402.

14. Lee KP, Kim JE, Park WH. Cytoprotective effect of rhamnetin on miconazole-induced H9c2 cell damage. Nutr Res Pract. 2015; 9(6): 586–591.

15. Mondal A, Rajalingam D, Kumar MT. Anti-inflammatory effect of O-methylated flavonol 2-(3,4-dihydroxy-phenyl)-3,5- dihydroxy-7-methoxy-chromen-4-one obtained from Cassia sophera Linn in rats. J Ethnopharmacol. 2013; 147: 525–529.

16. Lutz JA, Kulshrestha M, Rogers DT, Littleton JM. A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia. Fitoterapia. 2014; 98: 11-21.





17. Jnavali HN, Lee E, Jeong KW, Shin A Heo YS, Kim Y.Anti-inflammatory activity of rhamnetin and a model of its binding to c-Jun NH2-terminal kinase 1 and p38 MAPK. J Nat Prod. 2014; 77(2): 258-263.

18. Kozłowska A, Szostak-Węgierek D. Flavonoids - food sources and health benefits. Rocz Panstw Zakl Hig. 2014; 65(2): 79-85.

19. Osipov AV, Terpinskaya TI, Kryukova EV, Ulaschik VS, Paulovets LV, Petrova EA, Blagun EV, Starkov VG, Utkin YN. Nerve growth factor from cobra venom inhibits the growth of Ehrlich tumor in mice. Toxins (Basel). 2014; 6(3): 784-95.

20. Ertekin T, Ceylan D, Nisari M, Ülger H. Ehrlich ascites tumor model. J Health Sci. 2016; 25(2): 81-87.

21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2): 351-358.

22. Sun Y, Oberley LW, Elwell JH, Sierra‑Rivera E. Antioxidant enzyme activities in normal and transformed mouse liver cells. Int J Cancer. 1989; 44: 1028‑33.

23. Aebi H. Catalase. In: Burgmeyer HU, (ed) Methods of enzymatic analysis. Academic Press Publisher, New York, 1983; 273.

24. Sullivan LB, Chandel NS. Mitochondrial reactive oxygen species and cancer. Cancer Metabolism. 2014; 2: 1-17.

25. Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014; 92(1): 90-101.

26. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How they are linked? Free Radic Boil Med. 2010; 49(11): 1603-1616.

27. Jaganathan SK, Mondhe D, Wani ZA, Pal HC, Mandal M. Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. J Biomed Biotechnol. 2010.

28. Kumar RS, Rajkapoor B, Perumal P, Dhanasekaran T, Jose MA, Jothimanivannan C. Antitumor activity of Prosopis glandulosa Torr. on Ehrlich ascites carcinoma (EAC) tumor bearing mice. Iranian J Pharmaceut Res. 2011;10 (3): 505-510.

29. Kabel AM. Effects of combination between methotrexate and histone deacetylase inhibitors on transplantable tumor model. Am J Med Stud. 2014; 2(1): 12-18.

30. Ertekin T, Bozkurt O, Eroz R, Nisari M, Bircan D, Nisari M, Unur E.May argyrophilic nucleolar organizing region-associated protein synthesis be used for selecting the most reliable dose of drugs such as rhamnetin in cancer treatments? Bratislava Med J. 2016; 117(11): 653-658.

31. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160(1): 1-40. 32.Lü JM, Lin PH, Yao Q, Chen C.Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med. 2010; 14(4): 840-860.

32. Igarashi K, Ohmuma M. Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. Biosci Biotech Biochem. 1995; 59(4): 595-601.

DB Error: Unknown column 'Array' in 'where clause'